Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: Advantages and disadvantages

Tropical Medicine and International Health

Volumn 8, Issue 11, 2003, Pages 997-1004

  Ndyomugyenyi, Richard ^a   Kabatereine, Narcis ^a  

^a MINISTRY OF HEALTH   (Uganda)

Author keywords

Coverage; Integrated community directed treatment; Intestinal helminths; Ivermectin; Mebendazole; Onchocerciasis; Praziquantel; Schistosomiasis; Uganda

Indexed keywords

IVERMECTIN; MEBENDAZOLE; PRAZIQUANTEL;

DISEASE CONTROL; DRUG PRESCRIBING; FEASIBILITY STUDY; INTEGRATED APPROACH; ONCHOCERCIASIS; PARASITE CONTROL; SCHISTOSOMIASIS;

ABDOMINAL PAIN; ADOLESCENT; AFRICA; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DRUG MARKETING; ENDEMIC DISEASE; HEADACHE; HELMINTHIASIS; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INTEGRATED COMMUNITY DIRECTED TREATMENT; MAJOR CLINICAL STUDY; NAUSEA; ONCHOCERCIASIS; PREVALENCE; RURAL POPULATION; SCHISTOSOMIASIS; SYSTEMIC THERAPY; TREATMENT PLANNING; UGANDA; VOMITING;

ADOLESCENT; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; DECISION MAKING; FEASIBILITY STUDIES; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HELMINTHIASIS; HUMANS; INTESTINAL DISEASES, PARASITIC; IVERMECTIN; MEBENDAZOLE; ONCHOCERCIASIS; PRAZIQUANTEL; SCHISTOSOMIASIS; UGANDA;

VERMES;

EID: 0242408553     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-2276.2003.01124.x     Document Type: Article

References (23)

1. African Programme for Onchocerciasis Control, World Health Organization (1998) A practical guide for trainers of community-directed distributors. WHO, Geneva.
2. Allen HE, Crompton DWT, deSilva N, LoVerde PL & Olds GR (2002) New policies for using anthelmintics in high risk groups. Trends in Parasitology 18, 381-382.
3. Amazigo UV, Obono OM, Dadzie KY et al. (2002) Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96, S75-S92.
4. Anonymous (1998) Monitoring by Independent Scientists of Community Directed Treatment with Ivermectin in APOC Countries. African Programme for Onchocerciasis Control, Ouagadougou.
5. Frenzel K, Grigull L, Odongo-Aginya E et al. (1999) Evidence for long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. American Journal of Tropical Medicine and Hygiene 60, 927-931.
6. Homeida M, Braide E, Elhassan E et al. (2002) APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. Annals of Tropical Medicine and Parasitology 96, S93-S104.
7. Hopkins DR, Eigege A, Miri ES et al. (2002) Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. American Journal of Tropical Medicine and Hygiene 67, 266-272.
8. Kabatereine NB, Kazibwe F & Kemijumbi J (1996) Epidemiology of schistosomiasis in Kampala, Uganda. East African Medical Journal 73, 795-800.
9. Katabarwa MN, Richards FO & Ndyomugyenyi R (2000) In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainability of the African Programme for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 94, 485-495.
10. Montresor A, Engels D, Chitsulo L & Savioli L (2001) Development and validation of a "tablet pole" foe the administration of praziquantel in sub-Saharan Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 542-544.
11. Mott KE, Desjenx P, Moncayo A, Rangue P & de Raadt P (1990) Parasitic diseases and urban development. Bulletin of World Health Organization 68, 691-698.
12. Ndyomugyenyi R & Minjas JN (2001) Urinary schistosomiasis in schoolchildren in Dar-es-Salaam, Tanzania, and factors influencing its transmission. Annals of Tropical Medicine and Parasitology 95, 697-706.
13. Ndyomugyenyi R & Remme H (2002) Using ivermectin treatment coverage in schoolchildren monitored by schoolteachers as a proxy of population coverage in Uganda. Annals of Tropical Medicine and Parasitology 96, 53-60.
14. Ongom VL & Bradley DJ (1972) The epidemiology and consequences of Schistosoma masoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro. Transactions of the Royal Society of Tropical Medicine and Hygiene 66, 835-851.
15. Ongom VL, Owor R, Drundy R & Bradley DJ (1972) The epidemiology and consequences of Schistosoma mansoni infection in West Nile. II. Hospital investigations of a sample from Panyagoro community. Transactions of the Royal Society of Tropical Medicine and Hygiene 66, 852-863.
16. Remme J, Baker RHA, De Sole G et al. (1989) A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana 1. Effect of microfilaial reservoir and the transmission of Onchocerca volvulus. Tropical Medicine and Parasitology 40, 347-367.
17. Webbe G (1999) Community-wide treatment of schistosomiasis with praziquantel. Tropical Doctor 29, 172-176.
18. Williams EH, Hayes RJ & Smith PG (1996) Admissions to rural hospitals in the West Nile District of Uganda over a 27 years period. Journal of Tropical Medicine and Hygiene 89, 193-211.
19. World Health Organization (1993) The control of schistosomiasis, second report of the WHO expert committee. WHO Technical Report Series 830.
20. World Health Organization (1994) Report of the WHO informal consultation on Hookworm infection and anemia in girls and women, 5-7 December 1994.
21. World Health Organization (1996) Community Directed Treatment with Ivermectin. A Report of a Multi-country Study. WHO, Geneva (Document TDR/AFR/RP/96.1).
22. World Health Organization (1998) Guidelines for the Evaluation of Soil-transmitted Helminthiasis and Schistosomiasis at the Community Level. World Health Organization, Geneva (WHO/ CTD/SIP/98).
23. World Health Organization, (2002) Relationship between Levels of Involvement of Community Directed Distributors (CDDs) in other Health and Development Activities and their Performance of Community Directed Treatment with Ivermectin Functions. WHO, Geneva.